Paper Details

  1. Home
  2. Paper Details

Use of lenvatinib in the treatment of radioiodine-refractory differentiated thyroid cancer: a multidisciplinary perspective for daily practice.

Author: BartesBeate, CapdevilaJaume, DeandreisDesiree', DuranteCosimo, FarnellKate, LeboulleuxSophie, LocatiLaura Deborah, LusterMarkus, Netea-MaierRomana, NewboldKate, SingerSusanne, SykiotisGerasimos P

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

Follicular thyroid cancers generally have a favorable outcome. However, a small percentage of patients develop metastatic disease, some becoming radioiodine refractory. Optimizing therapeutic outcomes requires timely diagnosis, informed decisions about treatment, management of side effects, and strong patient-doctor communication.
Paper Details　
Original Abstract of the Article :
Most thyroid cancers of follicular origin have a favorable outcome. Only a small percentage of patients will develop metastatic disease, some of which will become radioiodine refractory (RAI-R). Important challenges to ensure the best therapeutic outcomes include proper, timely, and appropriate diag...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10448584/

データ提供：米国国立医学図書館（NLM）

Conquering Radioiodine-Refractory Thyroid Cancer: A Multidisciplinary Approach

The realm of oncology presents a constant struggle against cancer, with researchers constantly striving to develop new and effective treatments. This article delves into the challenges of managing differentiated thyroid cancer, particularly when it becomes resistant to radioiodine therapy. This situation can be quite challenging, requiring a multidisciplinary approach that brings together various medical specialists to provide comprehensive care.

A Collaborative Effort: A Multidisciplinary Team

The article emphasizes the importance of a collaborative approach, involving specialists from various disciplines such as endocrinology, nuclear medicine, surgery, and oncology. This collaborative team, working together like a caravan navigating the diverse landscapes of a desert, can provide the best possible care for patients facing radioiodine-refractory thyroid cancer. The article outlines key considerations for diagnosis, treatment planning, and management of side effects, ensuring a holistic approach to patient care.

Navigating the Cancer Landscape: A Journey of Hope

This article provides valuable insights into the challenges and potential solutions for managing radioiodine-refractory thyroid cancer. The multidisciplinary approach described offers a roadmap for effective treatment, offering hope for patients facing this complex and challenging condition. By working together, medical professionals can offer patients the best possible chance of achieving a positive outcome.

Dr. Camel's Conclusion

This article, like a wise and experienced camel guide, leads us through the intricate world of radioiodine-refractory thyroid cancer. By emphasizing a collaborative and multidisciplinary approach, it offers a beacon of hope for patients navigating this challenging terrain. This collaborative effort, like a caravan traversing a vast desert, can provide the best possible care and support to patients facing this complex condition.

Date :
  1. Date Completed 2023-08-09
  2. Date Revised 2023-11-03
Further Info :

Pubmed ID

37429326

DOI: Digital Object Identifier

PMC10448584

Related Literature

Article Analysis
・Side Effects of lenvatinib
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.